Table 1

Baseline characteristics of groups at randomisation*

CharacteristicCa+D group (n=44)Ca group (n=28)
Age (months)55 (15–144)42 (16–91)
Female Sex (%)25 (57%)17 (61%)
Duration of symptoms (months)21.5 (0.8–108)19.1 (0.5–61)
Radiographic score5.5 (2.6–9.5)5.9 (2.8–10)
Exposure to sunlight (h/day)2 (0–8)1 (0–8)
Exposed skin (%)31 (19–47)37 (19–47)†
Dairy product calcium intake (mg/day)11 (0–321)36 (0–200)
Dietary calcium intake (mg/day)174 (75–402)168 (70–589)
Dietary energy intake (kcal/day)1116 (477–1954)1046 (627–2318)
Height for age z-score−3.78 (−7.37 to −0.30)−3.02 (−5.97 to 0.27)
Weight for height z-score−0.04 (−2.58 to 1.91)−0.57 (−2.15 to 1.45)
Serum biochemistry
 Calcium (mmol/L)‡2.1 (1.6–4.0)2.1 (1.3–3.0)
 Corrected calcium (mmol/L)§2.0 (1.5–2.8)2.0 (1.2–2.5)
 Phosphorus (mmol/L)¶1.1 (0.4–2.3)1.2 (0.7–1.8)
 Alkaline phosphatase (U/L)599 (291–2670)522 (268–2183)
 Albumin (g/L)44 (30–78)45 (38–64)
 25(OH)D (nmol/L)**29.5 (0–50)31.7 (10–70)
 25(OH)D <30 nmol/L18 (41%)11 (39%)
Bone densitometry
Distal radius and ulna
 Areal bone density (g/cm2)0.127 (0.081–0.237)0.129 (0.057–0.189)
 Bone mineral content (g)0.245 (0.162–0.699)0.249 (0.072–0.567)
 Bone area (cm2)2.084 (1.494–2.996)2.096 (1.257–3.307)
Proximal 1/3 radius and ulna  
 Areal bone density (g/cm2)0.183 (0.130–0.304)0.194 (0.139–0.326)
 Bone mineral content (g)0.333 (0.239–0.656)0.342 (0.214–0.722)
 Bone area (cm2)1.878 (1.495–2.467)1.836 (1412–2.312)
  • *Data are shown as medians (range) for consistency in the table, because some variables have non-normal distributions.

  • †p<0.05 for comparison with Ca+D group.

  • ‡To convert values for calcium to milligrams per decilitre, multiply by 4.0.

  • §Corrected calcium (mmol/L)=total calcium (mmol/L)+0.02×(40–albumin (g/L)).

  • ¶To convert values for phosphorus to milligrams per decilitre, multiply by 3.1.

  • **To convert values for 25(OH)D to nanograms per millilitre, multiply by 0.40.